U.S. Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament/Braided) By Absorption (Absorbable, Non-absorbable), By Appli

U.S. Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament/Braided) By Absorption (Absorbable, Non-absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy, Iridectomy, Oculoplastic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers [ASCs]), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 - 2032


U.S. Ophthalmic Sutures Market is expected to demonstrate sturdy growth through 2032, owing to increasing technological advancements in the field. Technology plays a crucial role in the correction of visual difficulties. In addition, recent research has advanced scientific and clinical knowledge of how the eye functions, providing a basis for future sight-saving treatments. With the rising demand for ophthalmic disease treatment around the U.S., employment opportunities are also increasing, which is expected to impact the market positively in the coming years.

Besides, the industry will likely face hindrances due to lack of skilled ophthalmologists who do not have the required experience to use sutures in related ophthalmic procedures. However, the rising incidences of eye ailments along with the increasing geriatric population base will be a key factor driving the U.S. ophthalmic sutures industry growth in the future.

Overall, the U.S. ophthalmic sutures market is segmented in terms of type, material, coating, material structure, absorption, application, and end-use.

Considering the type, the synthetic segment share is expected to rise owing to increasing awareness regarding the advantages of synthetic ophthalmic sutures such as high level of flexibility, durability, cost-effectiveness, and high tensile strength. Besides, ophthalmologists are increasingly opting for such sutures to guarantee wound security. All these factors are anticipated to accelerate segmental growth during the estimated timeframe.

Based on material, the silk ophthalmic sutures segment accounted for over USD 47 million market share in 2022 and is estimated to grow at a robust pace by 2032. The growth can be attributed to product qualities such as non-absorbable, natural, and braided material, which has encouraged some ophthalmologists to use it for offering increased stability for longer duration.

By coating, the uncoated ophthalmic sutures segment is anticipated to hold a considerable share through 2032. The growth is attributable to the impeccable product features including permanent or dissolvable and braided or monofilament attributes. Moreover, these sutures are made from silk, polypropylene, nylon, or other material.

On the basis of material structure, monofilament sutures segment held approximately 58% market share in 2022 and is slated to demonstrate positive growth through 2032. The development can be ascribed to the constant innovations in monofilament sutures that has left key players hooked on for novel innovations in the marketplace.

Based on absorption, the non-absorbable ophthalmic sutures segment registered a market valuation of over USD 246 million in 2022. The segment is further expected to grow considerably through 2032 owing to its rising adoption in several ophthalmic surgeries, including cataract surgery, corneal transplantation surgery, and glaucoma surgery.

By application, the glaucoma surgery segment is expected to exhibit over 5% CAGR during 2023-2032, owing to the mounting demand for glaucoma surgical procedures in the U.S. As per credible reports, glaucoma costs the U.S. economy over USD 2.86 billion annually.

Considering the end-user, the ambulatory surgical centers segment is slated to witness massive growth through 2032. These centers offer better care facilities and timely treatment at affordable rates, which are expected to propel revenue growth globally.